-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on AbbVie, Raises Price Target to $325

Benzinga·10/21/2026 12:51:13
Barclays analyst Emily Field maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $300 to $325.